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Background: Lung tumors showing ground-glass opacities on high-resolution computed tomography indicate the
presence of inflammation, atypical adenomatous hyperplasia, or localized bronchioloalveolar carcinoma. We
adopted a two-staged video-assisted thoracoscopic lobectomy strategy involving completion lobectomy for
localized bronchioloalveolar carcinoma with an invasive component according to postoperative pathological
examination by permanent section after partial resection.
Methods: Forty-one patients with undiagnosed small peripheral ground-glass opacity lesions underwent partial
resection from 2001 to 2007 in Hokkaido University Hospital. Localized bronchioloalveolar carcinoma was classified
according to the Noguchi classification for adenocarcinoma. Malignant lesions other than Noguchi types A and B
were considered for completion lobectomy and systemic mediastinal lymphadenectomy. Perioperative data of
completion video-assisted thoracoscopic lobectomies were compared with data of 67 upfront video-assisted
thoracoscopic lobectomies for clinical stage IA adenocarcinoma performed during the same period.
Results: Postoperative pathological examination revealed 35 malignant and 6 non-malignant diseases. Histologically,
all of the malignant diseases were adenocarcinomas of Noguchi type A (n = 7), B (n = 9), C (n = 18), and F (n = 1).
Eleven of 19 patients (58%) with Noguchi type C or F underwent two-staged video-assisted thoracoscopic lobectomy.
Three patients refused a second surgery. There was no cancer recurrence. The two-staged lobectomy group had a
significantly longer operative time and more blood loss than the upfront lobectomy group. There was no surgical
mortality or cancer recurrence.
Conclusions: Two-staged lobectomy for undiagnosed small peripheral ground-glass opacity lesions showed
satisfactory oncological results. However, low compliance for and invasiveness of the second surgery are concerns
associated with this strategy.
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In 1995, Noguchi et al. proposed the classification of
adenocarcinoma into six pathologic types, A to F, based
on growth patterns [1]. Noguchi type A adenocarcinoma
is localized bronchioloalveolar carcinoma (LBAC), and
Noguchi type B adenocarcinoma is LBAC with foci of
structural alveolar collapse. Types A and B are not inva-
sive, show no lymph node metastasis, and have a 5-year
survival rate of 100%. Noguchi type C adenocarcinoma,
which is LBAC with foci of active fibroblastic proliferation,
has the potential for lymph node metastasis and has a
5-year survival rate of 75%. Noguchi type was subse-
quently reported to be associated with radiological find-
ings on high-resolution computed tomography (HRCT)
imaging [2-4]. Most cases of bronchioloalveolar carcinoma
(BAC), such as Noguchi types A, B, and C, have radio-
logical findings of ground-glass opacities (GGO) on
HRCT. Aoki et al. reported that most Noguchi type A or
B adenocarcinomas showed localized GGO on HRCT, and
that most Noguchi type C adenocarcinomas showed par-
tial GGO mixed with localized solid attenuation [2].
Kondo et al. reported that 81.8% of air-containing tumors
with less than 50% opacity on mediastinal window images
were Noguchi type A or B, and 88.7% of the solid-density
tumors with more than 50% opacity were Noguchi type C,
D, or F [3]. Kuriyama et al. reported that the percentage of
GGO in LBAC was significantly greater than that in
adenocarcinoma with or without a replacement growth
pattern [4]. That is, tumors that comprise a larger GGO
component on HRCT, especially tumors with pure GGO,
are likely to be Noguchi type A or B adenocarcinoma.
Given that tumors demonstrating pure GGO or mixed
GGO lesions with a slight solid part represent early-stage
cancer without invasiveness, they might be good candi-
dates for limited surgery with curative intent. The out-
come of limited surgery with curative intent for patients
with pure GGO lesions is reportedly satisfactory [5-7]. Al-
though BAC generally has a good prognosis, some cases,
especially type C, have lymph node involvement and re-
currence [8]. Some reports have investigated whether lim-
ited resection or lobectomy should be performed for GGO
lesions according to the intraoperative pathological diag-
nosis of Noguchi type based on frozen section of partially
resected specimens [9-12]. That is, if the tumor is diag-
nosed as Noguchi type A or B adenocarcinoma or nonin-
vasive carcinoma based on intraoperative pathological
examination with frozen section after partial resection,
then additional resection is not indicated unless the surgi-
cal margin is positive. If the tumor is diagnosed as another
Noguchi type of adenocarcinoma or invasive carcinoma,
lobectomy with mediastinal lymph node dissection is
performed successively. The above-mentioned studies
reported that the results of this therapeutic strategy are
satisfactory in terms of patient survival.However, there was a limitation in this therapeutic strat-
egy: intraoperative pathological examination sometimes led
to a misdiagnosis of Noguchi type or cancer invasiveness,
because the Noguchi type of adenocarcinoma was originally
diagnosed based on postoperative pathological examination
by permanent section [5,10,13]. Misdiagnosis of Noguchi
type would result in either over- or undertreatment in
the form of lobectomy for patients with noninvasive cancer
or insufficient limited surgery for patients with invasive
cancer, respectively.
To avoid these intraoperative pathologic diagnostic er-
rors and resultant inappropriate surgeries, we adopted
the following therapeutic strategy for patients with un-
diagnosed small peripheral GGO lesions for 7 years
(2001–2007). According to the pathological diagnosis by
permanent section after partial resection, patients with
Noguchi type A or B adenocarcinoma underwent post-
operative follow-up without two-staged lobectomy. For
other Noguchi type adenocarcinomas (including type C)
and cancers of other histological types, two-staged lob-
ectomy was considered. There have been no reports of a
therapeutic strategy similar to ours. We herein report
the perioperative and survival outcomes of this two-
staged lobectomy strategy based on pathological examin-
ation by permanent section in patients with undiagnosed
small peripheral GGO lesions.
Patients and methods
The therapeutic strategy for patients with undiagnosed
small peripheral GGO lesions in our institute is as follow-
ing. First, video-assisted thoracoscopic (VATS) partial re-
section was performed after obtaining informed consent
for the possibility of two-staged lobectomy. Based on post-
operative pathological examination by permanent section,
patients who were diagnosed with non-malignant disease
or Noguchi type A or B adenocarcinoma did not undergo
two-staged lobectomy. On the other hand, patients who
were diagnosed with adenocarcinoma other than Noguchi
type A or B or with cancers of other histologic types
underwent two-staged lobectomy if the patient met the
medical criteria for lobectomy and agreed to the second
surgery. The institutional review board of Hokkaido uni-
versity hospital approved this retrospective study and
waived the requirement for informed consent.
The subjects were 41 patients with undiagnosed small
peripheral GGO lesions who underwent pulmonary re-
section in Hokkaido University Hospital from January
2001 to December 2007. The clinicopathological data
were obtained from the medical charts. GGO was de-
fined as a localized or focal misty increase in lung at-
tenuation that did not obscure the underlying vascular
markings. Typical CT findings of GGO lesions were
shown in Figure 1. The peripheral lung field was defined
as the outer one-third of lung field on CT imaging. For
Figure 1 CT findings of pure (left) and mixed (right) ground-
glass opacity lesions.
Table 1 Patient characteristics
Characteristics The patients with GGO (n = 41)
Age (year)





Median value (range) 2.2 (0.5-18.8)
Location
Right upper lobe 24 (58.5%)
Right middle lobe 1 (2.4%)
Right lower lobe 1 (2.4%)
Left upper lobe 7 (17.1%)
Left lower lobe 8 (19.5%)
Tumor size on CT (mm)









Tumor size on specimen (mm)
Median value (range) 13 (5–22)
TNM classification
T1a N0 M0 33
T1b N0 M0 2
VATS wedge resection
Follow-up
Other primary lung cancer (n=19)
Peripheral small  GGO lesion 
(n=41) 











type A or B
(n=16)
Figure 2 Patient breakout in the present study.
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inserted to identify the location intraoperatively. Details
on the technique for inserting the 1.5-mm-diameter gold
markers into the lung have been previously reported
[14]. In brief, special equipment that was developed for
the insertion of gold markers using bronchoscopy was
used to insert the markers into small bronchi (Olympus,
Tokyo, Japan).
The usefulness and safety of our therapeutic strategy
for patients with undiagnosed small peripheral GGO le-
sions were statistically analyzed. To evaluate usefulness,
overall survival (OS) and DFS after resection were ana-
lyzed. OS was the period between the date of operation
and the date of death or the last date of confirmed sur-
vival. DFS was the period between the date of operation
and the date of recurrence or the last date of confirmed
recurrence-free survival. For patients who underwent
two-staged lobectomy, OS and DFS were the period be-
tween the date of first operation and the last date.
To evaluate safety, perioperative data of patients who
underwent two-staged VATS lobectomy (two-staged lobec-
tomy group), such as operative time, blood loss, ratio of
conversion to open thoracotomy from VATS lobectomy,
postoperative complications, period of postoperative drain-
age, length of postoperative hospital stay, and surgery-
related death, were compared with data of 67 patients with
adenocarcinoma who were diagnosed with clinical stage IA
disease and underwent VATS lobectomy during the same
period (upfront lobectomy group). The following patients
were excluded: patients who underwent partial resection of
another lobe at the same time and patients with a past his-
tory of lung resection. Conversion to open thoracotomy
from VATS lobectomy was performed if there was severe
adhesion of lymph nodes to the pulmonary artery, severe
adhesion of the pleura, or uncontrolled vascular injury.
Postoperative pulmonary fistula was defined as air leakage
that continued for more than 7 postoperative days or ne-

























0 12 24 36 48 60 72 84 96 108120132
Type C 18 18 18 17 12 10 3 2 2 1 0
Type A/B 16 16 16 15 13 13 10 9 5 3 0
Noguchi type A/B (n=16)
Noguchi type C     (n=18)
Figure 3 Overall survival curve of patients with undiagnosed
small peripheral ground-glass opacity lesions using our
therapeutic strategy based on postoperative pathological
examination by permanent section.
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Meier method. Comparison between the two-staged and
upfront lobectomy groups was performed using the
Mann–Whitney U test and chi-square test. All statistical
analyses were performed using StatView 5.0 software
(SAS Institute Inc., Cary, NC, USA). A p-value of <0.05
indicated a significant difference.Table 2 Patient characteristics in two-staged and upfront lob
Characteristics Two-staged lobectomy group (n
Age (y.o.)





Median value (range) 2.4 (1.4-18.8)
Location
Right upper lobe 6 (54.5%)
Right middle lobe 1 (9.1%)
Right lower lobe 0 (0%)
Left upper lobe 2 (18.2%)
Left lower lobe 2 (18.2%)
Tumor size on CT (mm)
Median value (range) 13 (9–20)
Tumor size on specimen (mm)
Median value (range) 15 (8–20)
TNM classification
T1a / T1b / T2a / T2b / T3 11 / 0 / 0 / 0 / 0
N0 / N1 / N2 11 / 0 / 0
Stage IA / IB / IIA / IIB / IIIA 11 / 0 / 0 / 0 / 0Results
The characteristics of 41 patients with preoperatively un-
diagnosed small peripheral GGO lesions are shown in
Table 1. The 41 patients comprised 16 males and 25 fe-
males with a median age of 63 years (range, 37–79 years)
and a median tumor size on CT of 13 mm (range, 5–
20 mm). The tumor location was the right upper lobe in
24 patients, left lower lobe in 8, left upper lobe in 7, right
middle lobe in 1, and right lower lobe in 1. The postopera-
tive pathological examination by permanent section
resulted in a pathological diagnosis of 35 malignant and 6
non-malignant diseases (4 atypical adenomatous hyperpla-
sia, a intrapulmonary bleeding and an inflammatory le-
sion). Histologically, all of the malignant diseases were
adenocarcinomas of Noguchi type A (n = 7), B (n = 9),
C (n = 18), and F (n = 1). Eight of 19 patients (42%) with
Noguchi type C and F did not undergo two-staged lobec-
tomy for the following reasons: preexisting diseases such
as intestinal pneumonia in 3 patients, patient refusal in 3,
and multiple lesions in 2. Finally, 11 patients (58%) under-
went two-staged VATS lobectomy with systemic lymph
node dissection (Figure 2). The median period between
partial resection and two-staged lobectomy was 44 days
(range, 14–248 days).
The median postoperative follow-up period was
67 months (range, 32–119 months) in 41 patients withectomy groups












35 / 18 / 8 / 1 / 5 0.063
60 / 3 / 4 0.532
47 / 8 / 4 / 4 / 4 0.353


























210 (20–550) 80 (0–1050) 0.014
Complication
3 (27.3%) 12 (17.9%) >0.999














11 (7–27) 11 (5–27) 0.480
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35 patients with malignant diseases. Although two patients
with Noguchi type C adenocarcinoma died of other dis-
eases, no patents had recurrence of lung cancer. In
patients with Noguchi type A or B adenocarcinoma, the
5-year OS and DFS were 100% (Figure 3). In patients with
Noguchi type C adenocarcinoma, the 5-year OS was
87.2% and the 5-year DFS was 100%.
Patient characteristics of the two-staged (n = 11) and up-
front lobectomy (n = 67) groups are shown in Table 2. The
tumor size of the two-staged lobectomy group was signifi-
cantly smaller than that of the upfront group (p = 0.0138).
None of the other factors were significantly different. To
evaluate safety, perioperative data of the two-staged group
were compared with those of the upfront group (Table 3).The two-staged group had a median operative time of
306 minutes (range, 199–499 minutes), which was signifi-
cantly longer than that of the upfront group, which had
a median value of 250 minutes (range, 141–469 minutes)
(p = 0.0069). The two-staged group had a median blood
loss of 210 ml (range, 20–550 ml), which was significantly
more than that of the upfront group, which had a median
value of 80 ml (range, 0–1050 ml) (p = 0.0138). The ratio
of conversion to open thoracotomy in the two-staged
group was higher (18.2%), but the difference was not sig-
nificant. There was no significant difference in other fac-
tors between the two groups.
Discussion
In this study, we reported the results of limited resection
for Noguchi type A and B BAC and two-staged lobec-
tomy for other primary lung cancers. In patients with
Noguchi type A or B adenocarcinoma (n = 16), the 5-
year OS and DFS were 100%. In patients with Noguchi
type C adenocarcinoma (n = 18), the 5-year OS and DFS
were 87.2% and 100%, respectively. Patient survival was
satisfactory and comparable with that of reports from
other institutes. The postoperative follow-up period in
the present study might not be long enough, because
adenocarcinoma often recurs after 5 postoperative years
[15,16].
There have been several reports on the therapeutic strat-
egy in which partial resection is initially performed for
tumors comprising a GGO component, and whether lobec-
tomy was added was determined based on the intraoperative
Noguchi type diagnosis on pathological examination by fro-
zen section [10-12]. Lobectomy was not added after partial
resection if the intraoperative pathological diagnosis
was Noguchi type A or B, and lobectomy was added
if another Noguchi type was diagnosed. Koike et al.
reported that this therapeutic strategy resulted in a 5-year
DFS of 93% and a 5-year disease-specific survival of 100%
[10]. Yamato et al. reported that this therapeutic strategy
resulted in no recurrence during 30 months of follow-up
[11]. Ichiki et al. reported that this therapeutic strategy
resulted in no recurrence and a 5-year OS of 100% in pa-
tients who were diagnosed with Noguchi A or B disease
on intraoperative pathological examination by frozen sec-
tion [12]. These reports demonstrated a good survival out-
come with this strategy.
There is a limitation in Noguchi type diagnosis based on
intraoperative pathological examination by frozen section.
Determination of the Noguchi type of adenocarcinoma was
originally based on postoperative pathological examination
by permanent section [1]. Yoshida et al. reported a 98%
diagnostic ratio on intraoperative pathological examination
by frozen section [13]. One patient was diagnosed with
Noguchi type B disease on intraoperative examination by
frozen section, but converted to Noguchi type C on
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et al. performed a prospective study in which limited resec-
tion was performed on 46 patients who were diagnosed
with noninvasive BAC on intraoperative pathological exam-
ination by frozen section. Three patients were diagnosed
with invasive adenocarcinoma on postoperative patho-
logical examination by permanent section [10]. Yamada
et al. reported that among 42 pure GGO lesions of 2 cm or
less, 3 were diagnosed as Noguchi type C and 1 was diag-
nosed as Noguchi type A or B on intraoperative patho-
logical examination by frozen section [5]. Ichiki et al.
reported that of 16 patients who were diagnosed with No-
guchi type A or B disease intraoperatively, 3 were diagnosed
with Noguchi C disease postoperatively [12]. Yoshida et al.
reported three recurrent patients who were diagnosed with
Noguchi type B disease on intraoperative examination and
underwent limited resection [17]. One had metachronous
cancer, one had recurrence of the bronchial stump, and an-
other had Noguchi type C disease on postoperative examin-
ation. Although whether lobectomy can prevent recurrence
in patients with Noguchi C disease is unclear, a two-staged
lobectomy strategy can avoid undertreatment.
We adopted a two-staged lobectomy strategy to avoid
misdiagnosis due to intraoperative pathological examin-
ation by frozen section for undiagnosed small peripheral
GGO lesions. That is, two-staged lobectomy was added
based on the results of postoperative pathological examin-
ation by permanent section after partial resection. No pa-
tients who underwent this protocol were subjected to
surgical overtreatment. However, of 19 patients with a
diagnosis other than Noguchi type A or B disease, 8 (42%)
did not undergo two-staged lobectomy. Although five of
them did not undergo this procedure for medical reasons,
three refused. There seems to be a problem with compli-
ance to undergo a second surgery. It might be psycho-
logically and financially overwhelming. The ratio of
undertreatment was higher than the ratio of misdiagnosis
based on intraoperative pathological examination in past
reports [12].
Eleven patients underwent two-staged VATS lobectomy.
The perioperative outcomes of these surgeries were com-
pared with those of upfront VATS lobectomy for c-stage
IA adenocarcinoma. Although there was no mortality in
either group and no significant differences in morbidity,
the time of operation and estimated blood loss were sig-
nificantly greater in the two-staged group than in the
upfront lobectomy group. The rate of conversion to open
thoracotomy was as high as 18% in the two-staged group,
although there was no significant difference with the up-
front lobectomy group (7.5%, p = 0.255). It is speculated
that two-staged lobectomy requires dissection of adhesions,
and thus results in a longer operative time, more blood loss,
and sometimes conversion to open thoracotomy. Two-
staged lobectomy seems more invasive than upfrontlobectomy. Recently, to avoid adverse effects of two-staged
surgery, we performed limited resection according to the
GGO ratio and standardized uptake value of PET-CT re-
gardless of Noguchi classification with permanent section.Conclusions
The therapeutic strategy for undiagnosed small periph-
eral GGO lesions (i.e., two-staged lobectomy based on
postoperative pathological examination by permanent
section after partial resection) had satisfactory onco-
logical results. However, there are concerns in terms of
the invasiveness of the procedure and low compliance
for two-staged lobectomy.
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